{"id":9297,"date":"2014-06-01T21:49:57","date_gmt":"2014-06-01T21:49:57","guid":{"rendered":"http:\/\/admin.acceleratingscience.com\/behindthebench\/?p=9297"},"modified":"2018-10-18T23:48:18","modified_gmt":"2018-10-18T23:48:18","slug":"prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing","status":"publish","type":"post","link":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/","title":{"rendered":"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing"},"content":{"rendered":"<p>It is not uncommon to have a list of potential variants from a given whole-genome or\u00a0<a class=\"jive-link-external-small\" href=\"http:\/\/www.lifetechnologies.com\/us\/en\/home\/life-science\/sequencing\/dna-sequencing\/exome-sequencing.html\" rel=\"nofollow\">whole-exome sequencing<\/a>\u00a0analysis to have some 15,000 variants that need to be thrown against dbSNP (to remove common variation first) then SIFT\u2019ed and PolyPhen\u2019ed (the commonly used tools to identify known or likely damaging mutations). Still, researchers are left with an unmanageable number of variants, and the functional determination to find the exact causative mutations that can lead to many fruitless searches afterwards.<\/p>\n<p>With this in mind, Damien Smedley (at the\u00a0<a class=\"jive-link-external-small\" href=\"http:\/\/www.ebi.ac.uk\/\" rel=\"nofollow\">European Bioinformatics Institute<\/a>\u00a0in Cambridge U.K.) presented his research at the recent 2014\u00a0<a class=\"jive-link-external-small\" href=\"https:\/\/www.eshg.org\/\" rel=\"nofollow\">European Society for Human Genetics<\/a>\u00a0in Milan Italy, entitled \u201cStrategies for Exome Prioritization of Human Disease Genes\u201d. He began his talk laying out current informatic methods used to winnow down a large list of SNVs from a given WES or WGS experiment (removal of low-quality SNVs, then use of tools like PolyPhen and SIFT). Additional methods are then recruited to further refine the list, including linkage analysis, trio analysis etc.<\/p>\n<p>It has been observed that a \u2018normal\u2019 individual human has on average 13,595 SNVs, of which ~313 are predicted to impact protein function. (Reference: Tennesson et al. Science May 17 2012, \u201cEvolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes\u201d, doi: 10.1026\/science.1219240 ) Now that\u2019s something to ponder, or at least impress someone at your next social event.<\/p>\n<p>Given the limitations of our understanding of genotype to phenotype, a new approach is needed.<\/p>\n<p>Enter the mighty mouse. (Not that one &#8211; more like \u2018really useful model organism\u2019\u00a0<em>Mus musculus<\/em>.) And the mighty zebrafish,\u00a0<em>Danio rerio<\/em>. These model organisms have already produced a wealth of wide-ranging phenotypic data from over 100 years\u2019 worth of genetic study (in the case of the mouse).<\/p>\n<p>His group developed an algorithm called PHIVE, which stands for PHenotypic Interpretation of Variants in Exomes, which takes into account phenotype similarity between the model organisms and human diseases, and integrated this PHIVE algorithm into a web-based tool called\u00a0<a class=\"jive-link-external-small\" href=\"http:\/\/www.sanger.ac.uk\/resources\/databases\/exomiser\/\" rel=\"nofollow\">Exomiser<\/a>. Variants are evaluated according to allele frequency, pathogenicity and mode of inheritance.<\/p>\n<p>Of course the proof of any tool is in the testing of it, and in their recent\u00a0<a class=\"jive-link-external-small\" href=\"http:\/\/genome.cshlp.org\/cgi\/pmidlookup?view=long&amp;pmid=24162188\" rel=\"nofollow\">Genome Research paper<\/a>\u00a0they were able to look at over 100,000 exomes containing known mutations. Their result reported some 54-fold improvement over purely variant-based methods (i.e. those that depend solely on frequency and predicted pathogenicity).<\/p>\n<p>He also presented data that analyzed exomes with potentially causative mutations from the NIH Undiagnosed Diseases program, showing that the causative mutation was found by their Exomiser tool in the top ten \u2018hits\u2019 a full 100% of the time, with 40% of the time it was the top variant.<\/p>\n<p>So take a look at this interesting approach, and then take the\u00a0<a class=\"jive-link-external-small\" href=\"http:\/\/www.sanger.ac.uk\/resources\/databases\/exomiser\" rel=\"nofollow\">Exomiser tool<\/a>\u00a0for a spin with your VCF file of choice.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>It is not uncommon to have a list of potential variants from a given whole-genome or\u00a0whole-exome sequencing\u00a0analysis to have some 15,000 variants that need to be thrown against dbSNP (to remove common variation first) then SIFT\u2019ed and PolyPhen\u2019ed (the commonly used tools to identify known or likely damaging mutations). Still, researchers are left with an<\/p>\n","protected":false},"author":111,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_monsterinsights_skip_tracking":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[84],"tags":[217,153,11,6,74,155,216],"division":[],"class_list":["post-9297","post","type-post","status-publish","format-standard","category-metagenomics","tag-eshg-2014","tag-genomic-variants","tag-ion-torrent","tag-next-generation-sequencing","tag-sequencing","tag-whole-exome-sequencing","tag-whole-genome-sequencing-large-genome","entry"],"_selected_authors":"","_selected_reviewers":"","acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.9 (Yoast SEO v28.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing - Behind the Bench<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing\" \/>\n<meta property=\"og:description\" content=\"It is not uncommon to have a list of potential variants from a given whole-genome or\u00a0whole-exome sequencing\u00a0analysis to have some 15,000 variants that need to be thrown against dbSNP (to remove common variation first) then SIFT\u2019ed and PolyPhen\u2019ed (the commonly used tools to identify known or likely damaging mutations). Still, researchers are left with an\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/\" \/>\n<meta property=\"og:site_name\" content=\"Behind the Bench\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thermofisher\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-01T21:49:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-18T23:48:18+00:00\" \/>\n<meta name=\"author\" content=\"Jeremy Schoales\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:site\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jeremy Schoales\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\\\/\"},\"author\":{\"name\":\"Jeremy Schoales\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/9f76f1ac4b703727182bf3c3d35a6e30\"},\"headline\":\"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing\",\"datePublished\":\"2014-06-01T21:49:57+00:00\",\"dateModified\":\"2018-10-18T23:48:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\\\/\"},\"wordCount\":477,\"commentCount\":0,\"keywords\":[\"ESHG 2014\",\"Genomic Variants\",\"Ion Torrent\",\"Next Generation Sequencing\",\"sequencing\",\"Whole Exome Sequencing\",\"Whole Genome Sequencing - Large Genome\"],\"articleSection\":[\"Metagenomics\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\\\/\",\"url\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\\\/\",\"name\":\"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing - Behind the Bench\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#website\"},\"datePublished\":\"2014-06-01T21:49:57+00:00\",\"dateModified\":\"2018-10-18T23:48:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/9f76f1ac4b703727182bf3c3d35a6e30\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#website\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/\",\"name\":\"Behind the Bench\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/9f76f1ac4b703727182bf3c3d35a6e30\",\"name\":\"Jeremy Schoales\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/434e3bc7a9dfe10c550461226113f8b4b327be55384e3a8a175ab1f2b6af039f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/434e3bc7a9dfe10c550461226113f8b4b327be55384e3a8a175ab1f2b6af039f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/434e3bc7a9dfe10c550461226113f8b4b327be55384e3a8a175ab1f2b6af039f?s=96&d=mm&r=g\",\"caption\":\"Jeremy Schoales\"},\"jobTitle\":\"Marketing Manager\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/author\\\/jeremy-schoales\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing - Behind the Bench","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/","og_locale":"en_US","og_type":"article","og_title":"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing","og_description":"It is not uncommon to have a list of potential variants from a given whole-genome or\u00a0whole-exome sequencing\u00a0analysis to have some 15,000 variants that need to be thrown against dbSNP (to remove common variation first) then SIFT\u2019ed and PolyPhen\u2019ed (the commonly used tools to identify known or likely damaging mutations). Still, researchers are left with an","og_url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/","og_site_name":"Behind the Bench","article_publisher":"https:\/\/www.facebook.com\/thermofisher","article_published_time":"2014-06-01T21:49:57+00:00","article_modified_time":"2018-10-18T23:48:18+00:00","author":"Jeremy Schoales","twitter_card":"summary_large_image","twitter_creator":"@thermofisher","twitter_site":"@thermofisher","twitter_misc":{"Written by":"Jeremy Schoales","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/#article","isPartOf":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/"},"author":{"name":"Jeremy Schoales","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/9f76f1ac4b703727182bf3c3d35a6e30"},"headline":"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing","datePublished":"2014-06-01T21:49:57+00:00","dateModified":"2018-10-18T23:48:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/"},"wordCount":477,"commentCount":0,"keywords":["ESHG 2014","Genomic Variants","Ion Torrent","Next Generation Sequencing","sequencing","Whole Exome Sequencing","Whole Genome Sequencing - Large Genome"],"articleSection":["Metagenomics"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/","url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/","name":"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing - Behind the Bench","isPartOf":{"@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#website"},"datePublished":"2014-06-01T21:49:57+00:00","dateModified":"2018-10-18T23:48:18+00:00","author":{"@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/9f76f1ac4b703727182bf3c3d35a6e30"},"breadcrumb":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/prioritize-human-disease-genes-from-whole-exome-or-whole-genome-sequencing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admin.acceleratingscience.com\/behindthebench\/"},{"@type":"ListItem","position":2,"name":"Prioritize Human Disease Genes from Whole Exome or Whole Genome Sequencing"}]},{"@type":"WebSite","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#website","url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/","name":"Behind the Bench","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admin.acceleratingscience.com\/behindthebench\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/9f76f1ac4b703727182bf3c3d35a6e30","name":"Jeremy Schoales","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/434e3bc7a9dfe10c550461226113f8b4b327be55384e3a8a175ab1f2b6af039f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/434e3bc7a9dfe10c550461226113f8b4b327be55384e3a8a175ab1f2b6af039f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/434e3bc7a9dfe10c550461226113f8b4b327be55384e3a8a175ab1f2b6af039f?s=96&d=mm&r=g","caption":"Jeremy Schoales"},"jobTitle":"Marketing Manager","url":"https:\/\/admin.acceleratingscience.com\/author\/jeremy-schoales\/"}]}},"taxonomy_info":{"category":[{"value":84,"label":"Metagenomics"}],"post_tag":[{"value":217,"label":"ESHG 2014"},{"value":153,"label":"Genomic Variants"},{"value":11,"label":"Ion Torrent"},{"value":6,"label":"Next Generation Sequencing"},{"value":74,"label":"sequencing"},{"value":155,"label":"Whole Exome Sequencing"},{"value":216,"label":"Whole Genome Sequencing - Large Genome"}]},"featured_image_src_large":false,"author_info":{"display_name":"Jeremy Schoales","author_link":"https:\/\/admin.acceleratingscience.com\/author\/jeremy-schoales\/"},"comment_info":0,"category_info":[{"term_id":84,"name":"Metagenomics","slug":"metagenomics","term_group":0,"term_taxonomy_id":84,"taxonomy":"category","description":"","parent":0,"count":26,"filter":"raw","meta":[],"cat_ID":84,"category_count":26,"category_description":"","cat_name":"Metagenomics","category_nicename":"metagenomics","category_parent":0}],"tag_info":[{"term_id":217,"name":"ESHG 2014","slug":"eshg-2014","term_group":0,"term_taxonomy_id":217,"taxonomy":"post_tag","description":"","parent":0,"count":3,"filter":"raw","meta":[]},{"term_id":153,"name":"Genomic Variants","slug":"genomic-variants","term_group":0,"term_taxonomy_id":153,"taxonomy":"post_tag","description":"","parent":0,"count":69,"filter":"raw","meta":[]},{"term_id":11,"name":"Ion Torrent","slug":"ion-torrent","term_group":0,"term_taxonomy_id":11,"taxonomy":"post_tag","description":"","parent":0,"count":167,"filter":"raw","meta":[]},{"term_id":6,"name":"Next Generation Sequencing","slug":"next-generation-sequencing","term_group":0,"term_taxonomy_id":6,"taxonomy":"post_tag","description":"","parent":0,"count":171,"filter":"raw","meta":[]},{"term_id":74,"name":"sequencing","slug":"sequencing","term_group":0,"term_taxonomy_id":74,"taxonomy":"post_tag","description":"","parent":0,"count":158,"filter":"raw","meta":[]},{"term_id":155,"name":"Whole Exome Sequencing","slug":"whole-exome-sequencing","term_group":0,"term_taxonomy_id":155,"taxonomy":"post_tag","description":"","parent":0,"count":9,"filter":"raw","meta":[]},{"term_id":216,"name":"Whole Genome Sequencing - Large Genome","slug":"whole-genome-sequencing-large-genome","term_group":0,"term_taxonomy_id":216,"taxonomy":"post_tag","description":"","parent":0,"count":10,"filter":"raw","meta":[]}],"jetpack-related-posts":[{"id":19885,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/sanger-sequencing-mix-dna-templates\/","url_meta":{"origin":9297,"position":0},"title":"Advancing the Gold Standard: Faster, Smarter, and Built for Challenging Templates","author":"Behind The Bench Staff","date":"August 5, 2026","format":false,"excerpt":"Sanger sequencing has long been the gold standard for accuracy, trusted by laboratories worldwide for applications ranging from plasmid verification to confirming next-generation sequencing results. Yet as research evolves, so do the demands placed on sequencing workflows. Today\u2019s labs are not only looking for accuracy\u2014they need speed, flexibility, and reliable\u2026","rel":"","context":"In &quot;General&quot;","block_context":{"text":"General","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/general\/"},"img":{"alt_text":"DNA sequencing sample tube with DNA helix and sequencing chromatogram representing Sanger sequencing workflow.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/ChatGPT-Image-Aug-5-2026-09_44_12-AM.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/ChatGPT-Image-Aug-5-2026-09_44_12-AM.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/ChatGPT-Image-Aug-5-2026-09_44_12-AM.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/ChatGPT-Image-Aug-5-2026-09_44_12-AM.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/ChatGPT-Image-Aug-5-2026-09_44_12-AM.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/ChatGPT-Image-Aug-5-2026-09_44_12-AM.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":19810,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/integration-site-analysis-gene-therapy-safety\/","url_meta":{"origin":9297,"position":1},"title":"Genotoxicity, vectors, and the power of integration site analysis","author":"Ashleigh Barlow","date":"June 23, 2026","format":false,"excerpt":"Article Summary In this episode of Absolute Gene-ius, Michael Stump, PhD, President of ProtaGene, and Matteo Franco, Lead Scientist at ProtaGene, discuss how integration site analysis is helping researchers evaluate genotoxicity risks in cell and gene therapy workflows. Their conversation explores how viral vectors integrate into the genome, why integration\u2026","rel":"","context":"In &quot;Gene Editing&quot;","block_context":{"text":"Gene Editing","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/gene-editing\/"},"img":{"alt_text":"Matteo Franco, Lead Scientist at ProtaGene, discussing integration site analysis and genotoxicity assessment","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/FRANCO-headshot_Jordan-Ruggieri.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/FRANCO-headshot_Jordan-Ruggieri.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/FRANCO-headshot_Jordan-Ruggieri.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/FRANCO-headshot_Jordan-Ruggieri.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/FRANCO-headshot_Jordan-Ruggieri.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/FRANCO-headshot_Jordan-Ruggieri.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":19509,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/cfdna-fragmentomics-analysis-qpcr-cancer-monitoring\/","url_meta":{"origin":9297,"position":2},"title":"qPCR-based fragmentomics for monitoring cancer disease progression","author":"Behind The Bench Staff","date":"March 5, 2026","format":false,"excerpt":"As fragmentomics gains momentum in cancer liquid biopsy research, attention is increasingly turning to how these structural cfDNA signals can be measured in a way that is both sensitive and practical. Established qPCR platforms offer an alternative to sequencing-based approaches for capturing fragment size information with high precision. Using a\u2026","rel":"","context":"In &quot;Bioinformatics&quot;","block_context":{"text":"Bioinformatics","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/bioinformatics\/"},"img":{"alt_text":"Scientist pipetting into a 96 well plate during qPCR workflow for cell free DNA fragmentomics analysis","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/03\/Picture1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/03\/Picture1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/03\/Picture1.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":19345,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/precision-oncology-diagnostics\/","url_meta":{"origin":9297,"position":3},"title":"The Expanding Role of Molecular Diagnostics in Precision Oncology","author":"Behind The Bench Staff","date":"January 13, 2026","format":false,"excerpt":"https:\/\/www.youtube.com\/watch?v=F6FfHIizJBY For Dr. Harald Bartsch, a clinical pathologist in southern Bavaria, molecular diagnostic tools have become an indispensable part of his arsenal. \u201cI believe molecular diagnostics play a crucial role in modern oncology, and I see this as the direction everything is headed,\u201d says Dr. Bartsch. While immunohistochemistry remains central\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Clinical Pathologist in a Molecular Diagnostics Laboratory","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":19883,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/building-a-better-sample-qc-workflow-from-extraction-to-sequencing\/","url_meta":{"origin":9297,"position":4},"title":"Building a Better Sample QC Workflow: From Extraction to Sequencing","author":"Marlene Gasdia-Cochrane","date":"August 25, 2026","format":false,"excerpt":"Article Summary Successful genomics experiments don't begin with sequencing\u2014they begin with sample quality. Every downstream application, from PCR to next-generation sequencing (NGS), depends on starting with nucleic acids that are accurately quantified and free from contaminants that could compromise results. Establishing a consistent quality control workflow helps laboratories improve reproducibility\u2026","rel":"","context":"In &quot;General&quot;","block_context":{"text":"General","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/general\/"},"img":{"alt_text":"A pipette drops a liquid into a petri dish with a dna sequence background, science concept. It suggests medical or genetic research.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/iStock-2216731026_petridish-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/iStock-2216731026_petridish-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/iStock-2216731026_petridish-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/iStock-2216731026_petridish-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/iStock-2216731026_petridish-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/iStock-2216731026_petridish-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":20004,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/a-guide-to-nucleic-acid-quality-control-dna-and-rna-purity\/","url_meta":{"origin":9297,"position":5},"title":"A Guide to Nucleic Acid Quality Control: DNA and RNA Purity","author":"Marlene Gasdia-Cochrane","date":"September 22, 2026","format":false,"excerpt":"Article Summary Nucleic acid quality control helps researchers evaluate DNA and RNA concentration and purity before downstream applications such as PCR, qPCR, and next-generation sequencing (NGS). A standardized workflow combining reliable extraction, concentration and purity assessment, application-appropriate quantification, and consistent laboratory practices can help identify sample issues early, improve reproducibility,\u2026","rel":"","context":"In &quot;General&quot;","block_context":{"text":"General","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/general\/"},"img":{"alt_text":"Close-up shot of a dna sequence on a screen, a digital representation of genetic code, used for analysis.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/iStock-2212923489_dnasequence-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/iStock-2212923489_dnasequence-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/iStock-2212923489_dnasequence-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/iStock-2212923489_dnasequence-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/iStock-2212923489_dnasequence-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/09\/iStock-2212923489_dnasequence-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts\/9297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/users\/111"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/comments?post=9297"}],"version-history":[{"count":0,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts\/9297\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/media?parent=9297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/categories?post=9297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/tags?post=9297"},{"taxonomy":"division","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/division?post=9297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}